Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Current Treatment Options in Oncology
|
May 1, 2020
Management of Myelofibrosis: from Diagnosis to New Target Therapies
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli
Current Treatment Options in Oncology
|
May 17, 2023
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs
Alessandra Iurlo, Cristina Bucelli, Daniele Cattaneo
Journal of Clinical Medicine
|
February 4, 2021
Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
International Journal of Molecular Sciences
|
August 23, 2020
New Perspectives on Polycythemia Vera: From Diagnosis to Therapy
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
Hematological Oncology
|
September 14, 2024
Treatment-free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects
Daniele Cattaneo, Cristina Bucelli, Valentina Bellani, et al.
Current Treatment Options in Oncology
|
December 4, 2023
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
British Journal of Haematology
|
October 21, 2022
Trend of circulating CD34<sup>+</sup> cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatment
Alessandra Iurlo, Nicole Galli, Cristina Bucelli, et al.
Frontiers in Oncology
|
September 30, 2022
Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event
Raffaella Pasquale, Cristina Bucelli, Valentina Bellani, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
April 5, 2016
Anagrelide and Mutational Status in Essential Thrombocythemia
Alessandra Iurlo, Daniele Cattaneo, Nicola Orofino, et al.
Leukemia Research
|
November 28, 2023
The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective
Carlo Pescia, Gianluca Lopez, Daniele Cattaneo, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Current Treatment Options in Oncology
|
May 1, 2020
Management of Myelofibrosis: from Diagnosis to New Target Therapies
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli
Current Treatment Options in Oncology
|
May 17, 2023
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs
Alessandra Iurlo, Cristina Bucelli, Daniele Cattaneo
Journal of Clinical Medicine
|
February 4, 2021
Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
International Journal of Molecular Sciences
|
August 23, 2020
New Perspectives on Polycythemia Vera: From Diagnosis to Therapy
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
Hematological Oncology
|
September 14, 2024
Treatment-free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects
Daniele Cattaneo, Cristina Bucelli, Valentina Bellani, et al.
Current Treatment Options in Oncology
|
December 4, 2023
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
British Journal of Haematology
|
October 21, 2022
Trend of circulating CD34<sup>+</sup> cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatment
Alessandra Iurlo, Nicole Galli, Cristina Bucelli, et al.
Frontiers in Oncology
|
September 30, 2022
Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event
Raffaella Pasquale, Cristina Bucelli, Valentina Bellani, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
April 5, 2016
Anagrelide and Mutational Status in Essential Thrombocythemia
Alessandra Iurlo, Daniele Cattaneo, Nicola Orofino, et al.
Leukemia Research
|
November 28, 2023
The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective
Carlo Pescia, Gianluca Lopez, Daniele Cattaneo, et al.
Page
of 6